17th Oct 2007 07:00
Dechra Pharmaceuticals PLC17 October 2007 Issued by Citigate Dewe Rogerson Ltd, BirminghamDate: Wednesday, 17 October 2007 Dechra(R) Pharmaceuticals PLC Interim Management Statement Dechra Pharmaceuticals PLC ("Dechra" or the "Group"), which holds its AnnualGeneral Meeting today at 10.00 am, publishes its first Interim ManagementStatement as required by the UK Listing Authority Disclosure and TransparencyRules. The Group has started the financial year in line with management expectations;there have been no significant changes in its financial position or performancesince the publication of the Annual Report in respect of the year ended 30 June2007 and the financial position of the Group remains strong. The Pharmaceuticals Division has continued its strong growth with revenue forthe first quarter of the financial year ahead of the same period last year. TheGroup's US operation is achieving encouraging revenues from the Pharmadermproducts acquired in May and is now trading profitably. The Services Division continues to take advantage of strong market conditions,with market share at National Veterinary Services remaining above 44%. There have been no material events or transactions between 1 July 2007 and thedate of this announcement. The Board remains confident that the Group will continue to make good strategicprogress in line with management expectations throughout the remainder of thefinancial year. Enquiries:Ian Page, Chief Executive Fiona Tooley, DirectorSimon Evans, Group Finance Director Keith Gabriel, Senior Account ManagerDechra Pharmaceuticals PLC Citigate Dewe RogersonTel: 01782 771100 Tel: 0121 455 8370Mobile: 07775 642222 (IP) or 07775 642220 (SE) Mobile: 07785 703523 (FMT) or 07770 788624 (KG)[email protected] Trade Marks appear throughout this release in italics. Dechra and the Dechra 'D' logo are registered Trade Marks of Dechra Pharmaceuticals PLC. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
DPH.L